Back to search

Article

Neuromedin U promotes lung adenocarcinoma progression by enhancing nucleotide metabolism and potentiating fibrosis in the tumor microenvironment

2025-12-05

Abstract excerpt

<title>Abstract</title> <p> Lung adenocarcinoma (LUAD) remains a leading cause of cancer mortality, with limited treatment options for EGFR-wild-type patients and persistent intrinsic resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in some EGFR-mutated cases. Neuromedin U (NMU), which encodes a neuropeptide previously associated with poor prognosis, has emerged as a candidate gene linked to reduced EGF...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5d917d9a-8d01-5c94-8246-fe7456f9440f
DOI
10.21203/rs.3.rs-8171505/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neuromedin U promotes lung adenocarcinoma progression by enhancing nucleotide metabolism and potentiating fibrosis in the tumor microenvironmentDOI 10.21203/rs.3.rs-8171505/v1
Select a neighboring publication to make it the new centre.